Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who would benefit from a posterior vitreous detachment, as determined by the evaluating ophthalmologist.~Exclusion Criteria:~* Presence of a posterior vitreous detachment in the study eye~* History of vitrectomy in the study eye~* Proliferative diabetic retinopathy in the study eye~* Presence of media opacity that precludes quality examination of the vitreous and fundus.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Plasmin Injection (Type: EXPERIMENTAL): human-derived plasmin
- Vehicle (Type: PLACEBO_COMPARATOR): Plasmin formulation, without active ingredient.

Based on this trial design, predict the completion outcome and termination type (if applicable).